Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wu, Hui Mei ^a   Jiang, Zi Feng ^a   Ding, Pei Shan ^a   Shao, Li Jie ^a   Liu, Rong Yu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; OXYGEN; TUMOR PROTEIN;

AUTOPHAGY; CELL HYPOXIA; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; HUMAN; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; CELL HYPOXIA; CELL LINE, TUMOR; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; OXYGEN;

EID: 84937854099     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12291     Document Type: Article

References (62)

1. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin. 55, 74-108 (2005).
2. Sui, X. et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 4, e838-849 (2013).
3. Belani, C. P. Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials. Clin Lung Cancer. 3 Suppl 1, S5-9 (2002).
4. Suehisa, H. & Toyooka, S. Adjuvant chemotherapy for completely resected non-small-cell lung cancer. Acta Med Okayama. 63, 223-230 (2009).
5. Liu, Y. et al. Apoptosis of HeLa cells induced by cisplatin and its mechanism. J Huazhong Univ Sci Technolog Med Sci. 28, 197-199 (2008).
6. Shamimi-Noori, S. et al. Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway. Cancer Gene Ther. 15, 356-370 (2008).
7. Ulukaya, E. et al. Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro. J Cancer Res Clin Oncol. 137, 1425-1434 (2011).
8. Cosse, J. P. & Michiels, C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med Chem. 8, 790-797 (2008).
9. Kunz, M. & Ibrahim, S. M. Molecular responses to hypoxia in tumor cells. Mol Cancer. 2, 23-35 (2003).
10. Degenhardt, K. et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 10, 51-64 (2006).
11. Papandreou, I., Lim, A. L., Laderoute, K. & Denko, N. C. Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. Cell Death Differ. 15, 1572-1581 (2008).
12. Mizushima, N. & Klionsky, D. J. Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr. 27, 19-40 (2007).
13. Terman, A. & Brunk, U. T. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res. 68, 355-365 (2005).
14. Lum, J. J. et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 120, 237-248 (2005).
15. Del Bello, B., Toscano, M., Moretti, D. & Maellaro, E. Cisplatin-induced apoptosis inhibits autophagy, which acts as a pro-survival mechanism in human melanoma cells. PLoS One. 8, e57236-57249 (2013).
16. Yang, C., Kaushal, V., Shah, S. V. & Kaushal, G. P. Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Renal Physiol. 294, F777-787 (2008).
17. Harhaji-Trajkovic, L., Vilimanovich, U., Kravic-Stevovic, T., Bumbasirevic, V. & Trajkovic, V. AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells. J Cell Mol Med. 13, 3644-3654 (2009).
18. Liu, D., Yang, Y., Liu, Q. & Wang, J. Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol. 28, 105-111 (2011).
19. White, E. Role of the metabolic stress responses of apoptosis and autophagy in tumor suppression. Ernst Schering Found Symp Proc. 4, 23-34 (2007).
20. Francois, A., Marchal, S., Guillemin, F. & Bezdetnaya, L. mTHPC-based photodynamic therapy induction of autophagy and apoptosis in cultured cells in relation to mitochondria and endoplasmic reticulum stress. Int J Oncol. 39, 1537-1543.
21. O'Donovan, T. R., O'Sullivan, G. C. & McKenna, S. L. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy. 7, 509-524 (2011).
22. Zhou, Y. et al. Autophagy inhibits chemotherapy-induced apoptosis through downregulating Bad and Bim in hepatocellular carcinoma cells. Sci Rep. 4, 5382-5390 (2014).
23. Notte, A., Ninane, N., Arnould, T. & Michiels, C. Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation. Cell Death Dis. 4, e638-650 (2013).
24. Noman, M. Z. et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res. 71, 5976-5986 (2011).
25. Song, J. et al. Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy. 5, 1131-1144 (2009).
26. Tracy, K. et al. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol. 27, 6229-6242 (2007).
27. Wohlkoenig, C. et al. Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells. Cancer Lett. 308, 134-143 (2011).
28. Strese, S., Fryknas, M., Larsson, R. & Gullbo, J. Effects of hypoxia on human cancer cell line chemosensitivity. BMC Cancer. 13, 331-341 (2013).
29. Knudsen, K. E. et al. RB-dependent S-phase response to DNA damage. Mol Cell Biol. 20, 7751-7763 (2000).
30. Erhardt, J. A. et al. Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban. Thromb Res. 103, 143-148 (2001).
31. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8, 445-544 (2012).
32. Denko, N. C. et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene. 22, 5907-5914 (2003).
33. Sowter, H. M., Ratcliffe, P. J., Watson, P., Greenberg, A. H. & Harris, A. L. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61, 6669-6673 (2001).
34. Hockel, M. & Vaupel, P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 93, 266-276 (2001).
35. Prabhakar, N. R. Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol. 90, 1986-1994 (2001).
36. Zhou, J., Schmid, T., Schnitzer, S. & Brune, B. Tumor hypoxia and cancer progression. Cancer Lett. 237, 10-21 (2006).
37. Semenza, G. L. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 20, 51-56 (2010).
38. Hussein, D., Estlin, E. J., Dive, C. & Makin, G. W. Chronic hypoxia promotes hypoxia-inducible factor-1alpha-dependent resistance to etoposide and vincristine in neuroblastoma cells. Mol Cancer Ther. 5, 2241-2250 (2006).
39. Melillo, G. Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol Cancer Res. 4, 601-605 (2006).
40. Brown, L. M. et al. Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1. Mol Pharmacol. 69, 411-418 (2006).
41. Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B. & Simon, M. C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol. 23, 9361-9374 (2003).
42. Yu, H. M. & Wang, T. C. Mechanism of cisplatin resistance in human urothelial carcinoma cells. Food Chem Toxicol. 50, 1226-1237 (2012).
43. Johnstone, R. W., Ruefli, A. A. & Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108, 153-164 (2002).
44. Kim, M. et al. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation. Cancer Res. 64, 4078-4081 (2004).
45. Mizushima, N. Methods for monitoring autophagy using GFP-LC3 transgenic mice. Methods Enzymol. 452, 13-23 (2009).
46. de Medina, P., Silvente-Poirot, S. & Poirot, M. Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation. Autophagy. 5, 1066-1067 (2009).
47. Herman-Antosiewicz, A., Johnson, D. E. & Singh, S. V. Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res. 66, 5828-5835 (2006).
48. Nishikawa, T. et al. Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells. Ann Surg Oncol. 17, 592-602 (2010).
49. de Bruin, E. C. & Medema, J. P. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev. 34, 737-749 (2008).
50. Maiuri, M. C. et al. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 16, 87-93 (2009).
51. Sui, X. et al. p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment. Autophagy. 7, 565-571 (2011).
52. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell. 81, 323-330 (1995).
53. Harrington, E. A., Bruce, J. L., Harlow, E. & Dyson, N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci USA. 95, 11945-11950 (1998).
54. Jeong, J. B., Hong, S. C., Jeong, H. J. & Koo, J. S. Arctigenin induces cell cycle arrest by blocking the phosphorylation of Rb via the modulation of cell cycle regulatory proteins in human gastric cancer cells. Int Immunopharmacol. 11, 1573-1577 (2011).
55. Bellot, G. et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol. 29, 2570-2581 (2009).
56. Mazure, N. M. & Pouyssegur, J. Hypoxia-induced autophagy: cell death or cell survival? Curr Opin Cell Biol. 22, 177-180 (2010).
57. Song, X. et al. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol. 58, 776-784 (2006).
58. Li, H. et al. Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res. 71, 3625-3634 (2011).
59. Higgins, D. F., Kimura, K., Iwano, M. & Haase, V. H. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle. 7, 1128-1132 (2008).
60. Schnitzer, S. E., Schmid, T., Zhou, J. & Brune, B. Hypoxia and HIF-1alpha protect A549 cells from drug-induced apoptosis. Cell Death Differ. 13, 1611-1613 (2006).
61. Zhang, J. & Ney, P. A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 16, 939-946 (2009).
62. Huang, Y., Zhao, J. J., Lv, Y. Y., Ding, P. S. & Liu, R. Y. Hypoxia down-regulates glucocorticoid receptor alpha and attenuates the anti-inflammatory actions of dexamethasone in human alveolar epithelial A549 cells. Life Sci. 85, 107-112 (2009).